Results 251 to 260 of about 66,057 (350)
CDG due to Defective Membrane Transporters: Update
ABSTRACT Congenital disorders of glycosylation are genetic defects in the glycoprotein and glycolipid glycan assembly and attachment. Some 200 CDG have been reported since the first clinical description in 1980. Most CDG are enzymatic deficiencies, but 13 (6.5%) are defects in the ER, Golgi apparatus (GA), and plasma membrane transporters.
D. Quelhas, C. R. Ferreira, J. Jaeken
wiley +1 more source
Targeting the NLRP3 inflammasome for calcium oxalate stones: pathophysiology and emerging pharmacological interventions. [PDF]
Boldt AM, Di Sole F.
europepmc +1 more source
ALDH2 polymorphisms are associated with increased risk of nephrolithiasis in humans, and Aldh2 deficiency promotes kidney stone formation in mice, especially under alcohol exposure. ABSTRACT Background Nephrolithiasis is a common urological disorder and has become a significant global public health issue.
Tao Liu +11 more
wiley +1 more source
Apoptosis Inhibitor of Macrophage (AIM) Modulates Calcium Oxalate-Induced Ureteral Fibrosis in AIM-Felinized Mice. [PDF]
Machida Y +11 more
europepmc +1 more source
Mesenchymal stem cell‐derived extracellular vesicles (EVs) from human cornea and bone marrow, cultured in 2D and 3D conditions, are characterized and tested for corneal nerve repair. 3D‐derived EVs show superior therapeutic efficacy and in vivo reinnervation.
Hamed Massoumi +17 more
wiley +1 more source
Effects of Toxic Concentrations of Cadmium, Lead, or Zinc on Leaf Morphology, Anatomy and Calcium Oxalate Content in Metallicolous and Non-Metallicolous Ecotypes of <i>Dianthus carthusianorum</i> L. [PDF]
Borkowska-Drela I +4 more
europepmc +1 more source
Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis.
Saeed R. Khan
openalex +2 more sources
INHIBITORS IN CALCIUM OXALATE CRYSTALS
openaire +3 more sources

